Company
United StatesPublic company, NYSE: ADCTADC Therapeutics, SA (NYSE: ADCT), New Providence, NJ – FDA Inspections
Inspection records and compliance data for ADC Therapeutics, SA in New Providence, New Jersey. 1 FDA inspection on record, last inspected December 22, 2020. Publicly traded as NYSE: ADCT.
Company Profile
This profile covers ADC Therapeutics, SA based in New Providence, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected December 22, 2020.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 22, 2020 | NAI | Biologics, Human Drugs · Bioresearch Monitoring | 1134544 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
ADC Therapeutics, SA
Stock ticker
ADCT
Exchange
NYSE
Share price
$1.63
Market cap
$207.5M
Price as of
November 6, 2026
FEI Number
3017610950
Address
430 Mountain Ave Ste 404, New Providence, New Jersey 07974, United States
Country
United States
ID: 7ed0d5d3-4153-4201-a6ae-505c2ddd28e8